The Role of Dopaminergic Agents and the Dopamine Receptor in Treatment for CHF

This publication has 17 references indexed in Scilit:

• The Dopamine Congener, Ibopamine, in Congestive Heart Failure
  Journal of Cardiovascular Pharmacology, 1984
• Beneficial Hemodynamic Effects of Oral Levodopa in Heart Failure
  New England Journal of Medicine, 1984
• Propylbutyldopamine: hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure.
  Circulation, 1983
• Hemodynamic Effects of Ibopamine in Patients with Idiopathic Congestive Cardiomyopathy
  Journal of Cardiovascular Pharmacology, 1983
• CARDIOVASCULAR DOPAMINE RECEPTORS: PHYSIOLOGICAL, PHARMACOLOGICAL AND THERAPEUTIC IMPLICATIONS
  Journal of Autonomic Pharmacology, 1982
• Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines
  Journal of Medicinal Chemistry, 1980
• Dobutamine: A New Synthetic Cardioactive Sympathetic Amine
  New England Journal of Medicine, 1979
• Effects of dobutamine in patients with acute myocardial infarction
  The American Journal of Cardiology, 1977
• The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
  Circulation, 1977
• Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
  Circulation, 1977